SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-23-009228
Filing Date
2023-12-19
Accepted
2023-12-19 08:00:24
Documents
14
Period of Report
2023-12-15
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nbio_8k.htm   iXBRL 8-K 20182
  Complete submission text file 0001477932-23-009228.txt   129271

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nbio-20231215.xsd EX-101.SCH 5720
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbio-20231215_lab.xml EX-101.LAB 12618
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nbio-20231215_cal.xml EX-101.CAL 898
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbio-20231215_pre.xml EX-101.PRE 7881
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nbio-20231215_def.xml EX-101.DEF 2099
8 EXTRACTED XBRL INSTANCE DOCUMENT nbio_8k_htm.xml XML 3171
Mailing Address 631 US HWY 1, SUITE 407 NORTH PALM BEACH FL 33408
Business Address 631 US HWY 1, SUITE 407 NORTH PALM BEACH FL 33408 612-961-5656
Nascent Biotech Inc. (Filer) CIK: 0001622057 (see all company filings)

IRS No.: 450612715 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-55299 | Film No.: 231495659
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)